Cargando…

Prevention of vertical transmission of hepatitis B virus infection

Hepatitis B virus (HBV) is the leading cause of chronic viral hepatitis. Annually, almost two million children younger than 5 years acquire the infection, mostly through vertical or horizontal transmission in early life. Vertical transmission of HBV is a high efficacy phenomenon ranging, in the abse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veronese, Piero, Dodi, Icilio, Esposito, Susanna, Indolfi, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311536/ https://www.ncbi.nlm.nih.gov/pubmed/34326618 http://dx.doi.org/10.3748/wjg.v27.i26.4182

Ejemplares similares

Treatment of hepatitis B virus infection in children and adolescents
por: Stinco, Mariangela, et al.
Publicado: (2021)

Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
por: Shi, Yi-Xian, et al.
Publicado: (2016)

Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment
por: Spera, Anna Maria
Publicado: (2022)

Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2022)

Human immune repertoire in hepatitis B virus infection
por: Zhan, Qiao, et al.
Publicado: (2021)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Overall Vertical Transmission of Hepatitis C Virus, Transmission Net of Clearance, and Timing of Transmission
por: Ades, Anthony E, et al.
Publicado: (2022)

Hepatitis B virus-persistent infection and innate immunity defect: Cell-related or virus-related?
por: Tang, Jian, et al.
Publicado: (2018)

Interaction between hepatitis B virus and SARS-CoV-2 infections
por: Xiang, Tian-Dan, et al.
Publicado: (2021)

Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule
por: Liu, Qiushi, et al.
Publicado: (2016)

Hepatitis B virus reactivation in rheumatoid arthritis
por: Wu, Ya-Li, et al.
Publicado: (2022)

Screening and prevention of hepatitis C virus reactivation during chemotherapy
por: Li, Yuan-Rung, et al.
Publicado: (2021)

Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Impact of coronavirus disease 2019 on prevention and elimination strategies for hepatitis B and hepatitis C
por: Rehman, Syed Tabish, et al.
Publicado: (2021)

Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger?
por: Lenci, Ilaria, et al.
Publicado: (2020)

Vertical Transmission of Hepatitis B Virus—An Update
por: di Filippo Villa, Diana, et al.
Publicado: (2023)

Neurological and psychiatric effects of hepatitis C virus infection
por: Faccioli, Jessica, et al.
Publicado: (2021)

Neurological manifestations of hepatitis E virus infection: An overview
por: Jha, Ashish Kumar, et al.
Publicado: (2021)

Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
por: Shih, Chih-An, et al.
Publicado: (2021)

The Emergence and Zoonotic Transmission of H10Nx Avian Influenza Virus Infections
por: Everest, Holly, et al.
Publicado: (2021)

SARS-CoV-2 infection in children in Parma
por: Dodi, Icilio, et al.
Publicado: (2020)

Chronic hepatitis B-associated liver disease in the context of human immunodeficiency virus co-infection and underlying metabolic syndrome
por: Amponsah-Dacosta, Edina, et al.
Publicado: (2020)

Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment
por: Yin, Guo-Qing, et al.
Publicado: (2022)

Hepatitis delta virus: From infection to new therapeutic strategies
por: Niro, Grazia A, et al.
Publicado: (2021)

Innate immune recognition and modulation in hepatitis D virus infection
por: Jung, Stephanie, et al.
Publicado: (2020)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
por: Crismale, James F, et al.
Publicado: (2019)

Vertical transmission of hepatitis B virus: challenges and solutions
por: Gentile, Ivan, et al.
Publicado: (2014)

Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
por: Gnyawali, Bipul, et al.
Publicado: (2022)

Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
por: Irshad, Mohammad, et al.
Publicado: (2017)

Risk assessment of hepatitis E transmission through tissue allografts
por: Villalba, Rafael, et al.
Publicado: (2022)

Functional interaction of endoplasmic reticulum stress and hepatitis B virus in the pathogenesis of liver diseases
por: Kim, So Young, et al.
Publicado: (2017)

Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease
por: Ladino, Marco, et al.
Publicado: (2017)

Exploration of transmission chain and prevention of the recurrence of coronavirus disease 2019 in Heilongjiang Province due to in-hospital transmission
por: Chen, Qi, et al.
Publicado: (2021)

Occult hepatitis B — the result of the host immune response interaction with different genomic expressions of the virus
por: Gherlan, George Sebastian
Publicado: (2022)

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection
por: Cloherty, Gavin, et al.
Publicado: (2016)

Vertical transmission of hepatitis B virus: propositions and future directions
por: Liu, Jin-Feng, et al.
Publicado: (2021)

Review on hepatitis B virus precore/core promoter mutations and their correlation with genotypes and liver disease severity
por: Kumar, Rajesh
Publicado: (2022)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Metabolic aspects of hepatitis C virus
por: El-Kassas, Mohamed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6h5o04p1lm03grmuqkkr5bk3eo